News & Articles

Results per page

25

3 Articles Found | Selected Filters:

Molzym GmbH & Co. KG Clear Filters

Product NewsLife Sciences

Molzym announces FDA Breakthrough Device Designation for its molecular diagnostic test system

FDA Breakthrough Device Designation for Sepsis, Joint & Implant Infections, Infective Endocarditis, Bacterial Meningitis

12 May 2021

Product NewsClinical Diagnostics

Automated sepsis diagnostic for fast testing in clinical laboratories

8 Dec 2020

Industry NewsLife Sciences

Molzym announces new Board of Directors to accelerate growth of its molecular diagnostic solutions

12 Jul 2020